Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment.

Bogacki P, Kabłak-Ziembicka A, Bryniarski K, Wrotniak L, Ostrowska-Kaim E, Żmudka K, Przewłocki T.

Postepy Kardiol Interwencyjnej. 2016;12(4):303-313. Epub 2016 Nov 17.

2.

Resolution of ischemic symptoms after percutaneous angioplasty for a symptomatic subclavian artery stenosis.

Wrotniak L, Kabłak-Ziembicka A, Rosławiecka A, Musiałek P, Bogacki P, Trystuła M, Żmudka K, Przewłocki T.

J Vasc Surg. 2016 Sep;64(3):684-91. doi: 10.1016/j.jvs.2016.04.031.

PMID:
27565589
3.

Factors related to the effectiveness of hypercholesterolemia treatment following hospitalization for coronary artery disease.

Jankowski P, Czarnecka D, Łukaszewska A, Łysek R, Wolfshaut-Wolak R, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A.

Pol Arch Med Wewn. 2016 Jun 23;126(6):388-94. doi: 10.20452/pamw.3447. Epub 2016 Jun 23.

4.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators.

Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y.

5.

Cardiac Rehabilitation in Real Life.

Jankowski P, Pajak A, Lysek R, Lukaszewska A, Wolfshaut-Wolak R, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Czarnecka D.

Medicine (Baltimore). 2015 Aug;94(32):e1257. doi: 10.1097/MD.0000000000001257.

6.

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.

Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Sundvall J, Tuomilehto J, Wood D, Rydén L; EUROASPIRE IV Investigators.

Eur Heart J. 2015 May 14;36(19):1171-7. doi: 10.1093/eurheartj/ehv008. Epub 2015 Feb 9.

PMID:
25670820
7.

Secondary prevention of coronary artery disease in contemporary clinical practice.

Jankowski P, Czarnecka D, Wolfshaut-Wolak R, Łysek R, Łukaszewska A, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A.

Cardiol J. 2015;22(2):219-26. doi: 10.5603/CJ.a2014.0066. Epub 2014 Oct 9.

PMID:
25299500
8.
9.

Genetic analysis of tolerance to the root lesion nematode Pratylenchus neglectus in the legume Medicago littoralis.

Oldach KH, Peck DM, Nair RM, Sokolova M, Harris J, Bogacki P, Ballard R.

BMC Plant Biol. 2014 Apr 17;14:100. doi: 10.1186/1471-2229-14-100.

10.

Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?

Jankowski P, Czarnecka D, Lysek R, Skrzek A, Smaś-Suska M, Mazurek A, Brzozowska-Kiszka M, Wolfshaut-Wolak R, Surowiec S, Bogacki P, Bryniarska-Mirek E, Bryniarski L, Grodecki J, Nessler J, Olszowska M, Podolec P, Kawecka-Jaszcz K, Pająk A.

Kardiol Pol. 2014;72(4):355-62. doi: 10.5603/KP.a2013.0350. Epub 2014 Jan 10.

11.

Age, sex, and secondary prevention of ischaemic heart disease in everyday practice.

Jankowski P, Czarnecka D, Wolfshaut-Wolak R, Łysek R, Łukaszewska A, Surowiec S, Loster M, Bogacki P, Bryniarska-Mirek E, Grodecki J, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A.

Kardiol Pol. 2013;71(12):1251-9. doi: 10.5603/KP.a2013.0148. Epub 2013 Jun 25.

12.

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.

PMID:
23562264
13.

Genetic analysis of tolerance to boron toxicity in the legume Medicago truncatula.

Bogacki P, Peck DM, Nair RM, Howie J, Oldach KH.

BMC Plant Biol. 2013 Mar 27;13:54. doi: 10.1186/1471-2229-13-54.

14.

Genetic structure of South Australian Pyrenophora teres populations as revealed by microsatellite analyses.

Bogacki P, Keiper FJ, Oldach KH.

Fungal Biol. 2010 Oct;114(10):834-41. doi: 10.1016/j.funbio.2010.08.002. Epub 2010 Aug 7.

PMID:
20943193
15.

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M; EMBOLDEN I (Trial 001) Investigators.

J Clin Psychiatry. 2010 Feb;71(2):150-62. doi: 10.4088/JCP.08m04995gre. Epub 2010 Jan 26.

PMID:
20122369
16.

Expression profiling and mapping of defence response genes associated with the barley-Pyrenophora teres incompatible interaction.

Bogacki P, Oldach KH, Williams KJ.

Mol Plant Pathol. 2008 Sep;9(5):645-60. doi: 10.1111/j.1364-3703.2008.00485.x.

PMID:
19018994
17.

Relationship between class I and II HLA antigens in schizophrenia and eye movement disturbances: a preliminary study.

Bogacki PA, Borkowska A, Wojtanowska-Bogacka M, Rybakowski JK.

Neuropsychobiology. 2005;51(4):204-10. Epub 2005 May 4.

PMID:
15870510
18.

Mapping of the root lesion nematode ( Pratylenchus neglectus) resistance gene Rlnn1 in wheat.

Williams J, Taylor P, Bogacki P, Pallotta M, Bariana S, Wallwork H.

Theor Appl Genet. 2002 Apr;104(5):874-879. Epub 2002 Feb 22.

PMID:
12582649
19.

[Prodromal period of the first episode of schizophrenia].

Bogacki P, Rybakowski J.

Psychiatr Pol. 1998 May-Jun;32(3):239-50. Review. Polish.

PMID:
9739177

Supplemental Content

Loading ...
Support Center